dihydroethidium has been researched along with fluorexon in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (fluorexon) | Trials (fluorexon) | Recent Studies (post-2010) (fluorexon) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 1,452 | 4 | 489 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callewaert, DM; LeFevre, J; Poulik, MD; Radcliff, G; Waite, R | 1 |
1 other study(ies) available for dihydroethidium and fluorexon
| Article | Year |
|---|---|
Quantification of effector/target conjugation involving natural killer (NK) or lymphokine activated killer (LAK) cells by two-color flow cytometry.
Topics: Cell Survival; Cells, Cultured; Cytotoxicity, Immunologic; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Immunity, Cellular; In Vitro Techniques; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Activation; Phenanthridines | 1991 |